Judit Demeter

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Journal: Blood

Published: January 05, 2026

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Journal: Blood

Published: January 05, 2026

Expert consensus opinion on the management of hairy cell leukemia in elderly patients.

Expert consensus opinion on the management of hairy cell leukemia in elderly patients.

Journal: Leukemia & lymphoma

Published: October 10, 2025

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A.

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A.

Journal: Pathology oncology research : POR

Published: February 13, 2025

Case Report: Importance of high-throughput genetic investigations in the differential diagnosis of unexplained erythrocytosis.

Case Report: Importance of high-throughput genetic investigations in the differential diagnosis of unexplained erythrocytosis.

Journal: Pathology oncology research : POR

Published: November 21, 2024

Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia.

Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia.

Journal: Pathology oncology research : POR

Published: July 18, 2024

Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Journal: Pathology oncology research : POR

Published: March 06, 2024

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Journal: Pathology oncology research : POR

Published: September 15, 2023

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Journal: The journal of pathology. Clinical research

Published: July 26, 2023

Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.

Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.

Journal: Pathology oncology research : POR

Published: June 29, 2023

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Journal: Journal of internal medicine

Published: June 01, 2023

Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.

Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.

Journal: Haematologica

Published: May 25, 2023

Showing 1-12 of 74

Last Updated: 09/26/2026